Cargando…
The miRNAs Role in Melanoma and in Its Resistance to Therapy
Melanoma is the less common but the most malignant skin cancer. Since the survival rate of melanoma metastasis is about 10–15%, many different studies have been carried out in order to find a more effective treatment. Although the development of target-based therapies and immunotherapeutic strategie...
Autores principales: | Varrone, Francesca, Caputo, Emilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037367/ https://www.ncbi.nlm.nih.gov/pubmed/32013263 http://dx.doi.org/10.3390/ijms21030878 |
Ejemplares similares
-
Role of miRNAs in Melanoma Metastasis
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2019) -
The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy
por: Dong, Linyinxue, et al.
Publicado: (2022) -
Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?
por: Varrone, Francesca, et al.
Publicado: (2021) -
miRNAs and Melanoma: How Are They Connected?
por: da Cruz, Adriana Taveira, et al.
Publicado: (2012) -
Role of miRNAs in the progression of malignant melanoma
por: Mueller, D W, et al.
Publicado: (2009)